LABT 8-K 2026-07-15

Lakewood-Amedex Biotherapeutics Inc. (LABT) 8-K dated 2026-07-15 — accession 0001213900-26-078328.

Lakewood-Amedex Biotherapeutics Inc. (LABT) common stock.

Lakewood-Amedex Biotherapeutics Inc. filed a 8-K on 2026-07-15. Accession 0001213900-26-078328.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for LABT is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The LABT SEC hub lists recent forms. The stock page is the research view.